Oncoclínicas do Brasil Serviços Médicos Future Growth
Future criteria checks 4/6
Oncoclínicas do Brasil Serviços Médicos is forecast to grow earnings and revenue by 36.6% and 17.1% per annum respectively. EPS is expected to grow by 46.1% per annum. Return on equity is forecast to be 18.8% in 3 years.
Key information
36.6%
Earnings growth rate
46.1%
EPS growth rate
Healthcare earnings growth | 44.6% |
Revenue growth rate | 17.1% |
Future return on equity | 18.8% |
Analyst coverage | Good |
Last updated | 13 Mar 2024 |
Recent future growth updates
Recent updates
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet
Mar 11What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?
Feb 17It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Dec 08Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching
Nov 06Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?
Sep 11Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price
Apr 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 9,138 | 679 | 1,744 | 2,364 | 4 |
12/31/2025 | 7,853 | 566 | 1,385 | 1,989 | 7 |
12/31/2024 | 6,779 | 403 | 1,121 | 1,765 | 9 |
12/31/2023 | 5,520 | 225 | 1,082 | 1,811 | 9 |
9/30/2023 | 5,271 | 219 | -33 | 285 | N/A |
6/30/2023 | 5,033 | 145 | -253 | 78 | N/A |
3/31/2023 | 4,574 | 91 | -646 | -346 | N/A |
12/31/2022 | 4,088 | 46 | -576 | -272 | N/A |
9/30/2022 | 3,640 | -10 | -740 | -378 | N/A |
6/30/2022 | 3,155 | 105 | -593 | -324 | N/A |
3/31/2022 | 2,895 | -67 | -415 | -185 | N/A |
12/31/2021 | 2,702 | -47 | -211 | -9 | N/A |
9/30/2021 | 2,509 | -203 | -138 | 27 | N/A |
6/30/2021 | 2,354 | -334 | -128 | 9 | N/A |
3/31/2021 | 2,182 | -145 | -17 | 154 | N/A |
12/31/2020 | 2,035 | -158 | -19 | 186 | N/A |
12/31/2019 | 1,690 | -20 | -93 | 97 | N/A |
12/31/2018 | 1,051 | -17 | -296 | -18 | N/A |
12/31/2017 | 792 | 3 | 101 | 135 | N/A |
12/31/2016 | 595 | -25 | N/A | -21 | N/A |
12/31/2015 | 458 | -25 | N/A | -3 | N/A |
12/31/2014 | 359 | -22 | N/A | 9 | N/A |
12/31/2013 | 269 | 21 | N/A | 7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ONCO3's forecast earnings growth (36.6% per year) is above the savings rate (9.8%).
Earnings vs Market: ONCO3's earnings (36.6% per year) are forecast to grow faster than the BR market (14.5% per year).
High Growth Earnings: ONCO3's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ONCO3's revenue (17.1% per year) is forecast to grow faster than the BR market (6.7% per year).
High Growth Revenue: ONCO3's revenue (17.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ONCO3's Return on Equity is forecast to be low in 3 years time (18.8%).